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Purpose: To examine whether higher adherence to Baltic Sea diet (BSD) and Mediterranean diet 2 
(MED) have beneficial association with sarcopenia indices in elderly women. 3 
Methods: In total 554 women, aged 65–72 years belonging to OSTPRE-FPS study filled a questionnaire 4 
on lifestyle factors and 3-day food record at baseline in 2002. Intervention group received calcium 1000 5 
mg/d and cholecalciferol 800 IU for 3 years. Control group received neither supplementation nor placebo. 6 
Body composition was measured by dual-energy X-ray absorptiometry. Physical function measures 7 
included walking speed 10m, chair rises, one leg stance, knee extension, handgrip strength and squat at 8 
baseline and at year 3. Sarcopenia and short physical performance battery (SPPB) score were defined 9 
based on the European working group on sarcopenia criteria. Lower body muscle quality (LBMQ) was 10 
calculated as walking speed 10m/ leg muscle mass. BSD and MED scores were calculated. 11 
Results: Women in the higher quartiles of BSD and MED scores lost less relative skeletal muscle 12 
index and total body lean mass (LM) over 3-year follow-up (Ptrend ≤0.034). At the baseline, women in 13 
the higher BSD score quartiles had greater LM, faster walking speed 10m, greater LBMQ, higher SPPB 14 
score (Ptrend ≤ 0.034), and higher proportion of  squat test completion. Similarly, women in the higher 15 
quartiles of MED sore had significantly faster walking speed 10m, greater LBMQ (Ptrend ≤0.041) and 16 
higher proportion of squat test completion. 17 
Conclusions: Better diet quality as measured by higher adherence to BSD and MED might reduce the 18 




Sarcopenia, the degenerative and involuntary loss of skeletal lean mass (LM) and physical function (PF), 21 
has been determined as a major cause of mobility disability, and loss of independence. Sarcopenia is 22 
estimated to affect one-quarter of the elderly [1-3]. The pathogenesis of sarcopenia is multifactorial and 23 
is attributed to undernutrition, oxidative stress, inflammation, endocrine changes and physical inactivity 24 
[4]. Studies that assessed the role of nutrition in sarcopenia have focused on specific components of 25 
foods, often single nutrients. Although these studies have consistently provided knowledge for benefits 26 
of nutritional factors such as vitamin D, vitamin E, carotenoids, energy, protein, and whole grains in 27 
ageing sarcopenia [5, 6], this approach has limitations [7]. The role of a single factor is often small and 28 
difficult to capture in observational studies; also, people eat foods, not nutrients. Thus, dietary score 29 
analysis is a sensible approach to understand the role of the whole diet on sarcopenia. 30 
A dietary score represents a summary value of consumed foods or nutrients and characterizes a measure 31 
of adherence to a predefined (healthy) diet [8, 9], in which higher scores indicate diet quality and a higher 32 
intake of beneficial foods (such as whole grains, vegetables, fruits, and fish). In the past years, 33 
Mediterranean (MED) and Baltic Sea diets (BSD) have been related to positive health outcomes and 34 
received growing attention in European and particularly in Nordic settings (Denmark, Finland, Iceland, 35 
Norway and Sweden) [8, 10]. The MED is a model of a healthy diet that represents the dietary pattern in 36 
population from the Mediterranean area which has also been frequently applied in other populations [8]. 37 
However, due to the differences in food culture, applying MED directly to the Nordic population could 38 
be challenging [10]. BSD was therefore initially developed in order to present the healthier choices for 39 
the diet consumed in the Nordic countries [10, 11]. Many foods cultivated in the Nordic countries, for 40 
example, apples and berries, rye, rapeseed oil, salmon and dairy products, are considered to have health-41 
enhancing features [12]. Higher adherence to MED has consistently been associated with lower cognitive 42 
functional decline, less dementia and better PF in the elderly [8, 13, 14]. It was shown that higher 43 
adherence to MED was associated with better lower body performance [15].  Higher adherence to the 44 
MED was associated also with lower odds of sarcopenia among elderly men and women [14]. However, 45 
to our knowledge the association of MED with sarcopenia in Nordic countries has not been studied. BSD 46 
is likely to be inversely associated with abdominal obesity [11] , and it was associated with better overall 47 
physical performance in elderly Finnish women [16]. 48 
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Studies examining the effect of diet quality on indices of sarcopenia in the elderly are scarce. We 49 
hypothesized that higher adherence to BSD and MED provide a wide range of foods and nutrients that 50 
can benefit LM and PF. We evaluated and compared the associations of BSD and MED scores with LM, 51 
and PF measures in Finnish elderly women in both cross-sectional and prospective settings. 52 
METHODS 53 
Study population 54 
Data of the present study were collected from the Osteoporosis Risk Factor and Prevention - Fracture 55 
Prevention Study (OSTPRE-FPS), which was a 3-year intervention to investigate the effect of calcium 56 
and vitamin D supplementation on incidence of falls and fractures among elderly women. The subjects 57 
were selected from the population-based OSTPRE-cohort [17]. In total 3432 women volunteered to 58 
participate in the study, and 750 women were randomly invited into this subsample for participating in 59 
detailed examinations including measurement of body composition, clinical, physical and laboratory 60 
tests [18]. Of these, 554 returned valid food record at baseline and had valid body composition and PF 61 
measurements for both at the baseline and at the 3-year follow-up. The subjects were randomized to 62 
intervention group (n=272) receiving daily cholecalciferol 800 IU and calcium 1000 mg for 3 years and 63 
control group receiving neither supplementation nor placebo (n=282). All clinical measurements were 64 
performed in Kuopio Musculoskeletal Research Unit of the Clinical research center of the University of 65 
Kuopio. All participants provided written permission for participation. The study was approved in 66 
October 2001 by the ethical committee of Kuopio University Hospital. The study was registered in 67 
Clinical trials.gov by the identification NCT00592917. 68 
Dietary intakes 69 
Dietary intake was assessed by using a 3-day food record at the baseline. A questionnaire and the 70 
instructions were sent to participants beforehand, and they were returned on the visiting day. 71 
Questionnaire included 3 consecutive days, with 2 days during the week and one day in the weekend 72 
(Saturday or Sunday). In case of uncertainties in the food record, a nutritionist called the participant for 73 
additional information [19]. Assessment of underreporting has previously been described and none of 74 
the participants was excluded due to low energy intake [18]. Consumption of foods and the intake of 75 




Baltic Sea diet score 78 
We used published definitions of BSD and that have been applied in Nordic settings with slight 79 
modifications due to different dietary assessment methods in earlier studies [10]. The final BSD score 80 
consisted of nine components, of which five are foods or food groups and four nutrient intakes. The BSD 81 
score components included 1) fruits and berries, 2) vegetables (root vegetables, legumes, nuts, 82 
mushrooms and vegetable products– potatoes excluded), 3) fiber from cereal products, 4) low-fat milk 83 
(skim milk and milk with fat content less than 2 %), and 5) total fish intake as positive components and 84 
6) processed meat products (sausage) as a negative component. 7) Total fat intake was expressed as a 85 
percentage of total energy intake (E%). 8) Quality of fat intake was represented by calculating a ratio of 86 
polyunsaturated fatty acids (PUFA) to saturated fatty acid (SFA). 9) Frequency of consumption of 87 
alcohol portions (1 portion=12 g) was asked in a separate questionnaire. The score construction is 88 
presented in Table 1. BSD score ranged from 0–25, higher points indicating higher adherence to BSD. 89 
Mediterranean diet score 90 
MED score is the most widely used diet score [8]. A predefined MED score was selected based on the 91 
existing literature and particularly those studies that have applied the MED score in Nordic cohorts [8, 92 
20, 21], as well as on the suggested positive association of MED score with PF [13]. The score comprised 93 
of six positive components, including 1) high intake of root vegetables, legumes and nuts, mushrooms 94 
and vegetable products (potato excluded), 2) high intake of fruit, 3) high intake of cereals and potatoes, 95 
4) high intake of fish, 5) high PUFA+ monounsaturated fatty acid (MUFA): SFA ratio (as surrogate of 96 
quality of dietary fat), and 6) moderate alcohol intake. Two negative components were included 7) total 97 
meat including sausage and eggs, and 8) total milk and dairy products. Construction of MED score is 98 
described in Table 1. Those who met all of the MED score components received a score of 8, reflecting 99 
maximum adherence. 100 
Health examination and measurements 101 
All the information related to lifestyle, income per month, chronic diseases, falls and medications was 102 
gathered by using a self-administered questionnaire [22]. Height and weight of participants were 103 
measured in light indoor clothing without shoes, and BMI was calculated kg/m2. Total exercise 104 
time/week was based on self-reported amounts and types of exercise/week. To measure body 105 
composition whole body dual-energy X-ray absorptiometry (DXA) scans were performed by specially 106 
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trained nurses [23]. Relative skeletal muscle index (RSMI) was calculated as the sum of the nonfat, 107 
nonbone skeletal muscle in arms and legs divided by the square of height (m2) which is an indicator of 108 
LM in the diagnosis of sarcopenia [3].  109 
Physical function measurements 110 
PF measures were assessed by trained nurses at the baseline and at year 3, consisting of  handgrip strength 111 
(kPa), number of chair rises in 30 seconds, ability to squat, knee extension (kPa), maximal walking speed 112 
10 m (m/s), and one leg stance performance for 30 seconds. Handgrip strength was measured in a 113 
controlled sitting position with a pneumatic hand-held dynamometer (Martin Vigorimeter, Germany) by 114 
calculating the mean of three successive measurements from the dominant hand [18] . The chair rise test 115 
was conducted if participant was able to stand at least once without using arms from a straight-backed, 116 
non-padded, armless chair. Maximal walking speed was calculated by the time of walking the 10 m. Any 117 
measurement errors were excluded from the statistical analysis [22]. The follow-up variable of knee 118 
extension was excluded from analysis due to unexpected increase in measured extension force and/or 119 
possible data entry errors. Absolute changes in PF measures were calculated by subtracting the baseline 120 
measures from those measured at year 3. PF assessment methodology have been described and applied 121 
earlier in this data set [18, 22]. 122 
Short physical performance battery (SPPB) score was calculated based on European working group on 123 
sarcopenia (EWGSOP) definition [24]. Three individual measures of physical performance including 124 
walking speed 10 m (m/s), chair rises in 30 seconds and one leg stance performance were included [25]. 125 
Individuals unable to complete the task received a score of 0, PF tests were further categorized in quartiles 126 
and each quartile was scored on scale of 1-4 points. The total SPPB score ranging from 0 to 12; higher 127 
scores indicate better performance. Previous studies indicated that an SPPB cut point of less than 10 128 
identifies individuals at increased risk of mobility disability [26] . However, due to the different study 129 
setting and that only 8 percent of women had SPPB score over 10, we defined the development of 130 
“mobility disability” as an SPPB score belonging to the lowest quartile. The lower body muscle quality 131 
(LBMQ) was calculated using walking speed 10 m per leg LM, explained by association between lower 132 
leg LM and poorer low extremity performance and walking speed in older men and women [27, 28]. 133 
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Diagnosis of sarcopenia 134 
We have previously defined sarcopenia based on EWGSOP criteria in this data set [18, 22]. In brief, 135 
women were subdivided into quartiles according to their RSMI, handgrip strength and walking speed 136 
values (the women who were not able to perform the tests allocated into the group of the lowest quartile). 137 
A woman was classified as sarcopenic if she belonged to the lowest quartile of RSMI and the lowest 138 
quartile of either handgrip strength or walking speed or both. A non-sarcopenic woman did not belong 139 
to the lowest quartile of any measurement, whereas pre-sarcopenic women were in the lowest quartile of 140 
RSMI but not in the lowest quartile of any other outcome measure. Non-classified women belonged to 141 
the lowest quartile of either handgrip strength or walking speed or both, but not to that of RSMI. To 142 
achieve balanced numbers of participants in the stratified analysis, women were classified as sarcopenic 143 
if they belonged to pre-sarcopenia, sarcopenia and severe sarcopenia (lowest quartile of RSMI) and non-144 
sarcopenic group was compiled from non-sarcopenic and non-classified groups (normal RSMI). 145 
Statistical analysis 146 
We reported MED and BSD scores in quartiles to enable comparability of their results. We analyzed  147 
BSD and MED score also as continuous variables. The agreement between the MED and BSD score was 148 
not significant (kappa value= 0.020 and P= 0.148). We compared the participant characteristics 149 
according to BSD and MED score quartiles using chi-square analysis or ANOVA, as appropriate. 150 
Independent sample t-test was used to compare the baseline characteristic between sarcopenic and non-151 
sarcopenic groups as well as intervention and control groups. 152 
For the cross-sectional analysis, the baseline values of LM, RSMI and PF measures were tested in total 153 
population. In the follow-up analysis, we tested the interaction terms between BSD and MED with 154 
vitamin D and calcium intervention. There was no significant interaction by intervention; therefore, data 155 
were pooled for total population (intervention and control group) adjusted for the intervention. However, 156 
to account for the possible effect of vitamin D and calcium intervention, we tested further the associations 157 
only in the control group. In the prospective analysis, we used the absolute changes of PF measures, and 158 
the proportional change of LM and RSMI to correct for effect of body size since bigger individuals have 159 
greater LM. ANCOVA was used to test the differences among the groups, multiple linear regression 160 
models were used to calculate (β) and SE introducing LM, RSMI and PF at the baseline and changes in 161 
them as dependent variables with BSD or MED score as independent variable. Logistic regression was 162 
used to determine the association of BSD and MED with categorical outcomes (sarcopenia, mobility 163 
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disability, and squat test). P-trend was based on a linear trend across BSD and MED score quartiles by 164 
using the median value in each category as a continuous variable in the linear regression model as 165 
exposure. 166 
We used two models with hierarchical adjustments. Model 1 was adjusted for age and energy intake. 167 
Model 2 was adjusted for variables in model 1 and smoking, total physical activity, hormone therapy, 168 
osteoporosis, rheumatoid arthritis, income per month, and fat mass percentage. Depression, diabetes, and 169 
fall were not included in the models because their associations with the diet scores and outcome measures 170 
in the bivariate correlation analysis were P > 0.10. Longitudinal analyses were adjusted for the muscle 171 
mass and PF baseline measures to account for differential subsequent changes depending on the initial 172 
measures. All statistical analysis were executed using SPSS software version 21 for Windows (IBM 173 
Corp., Armonk, NY). Result was considered significant if a P value was < 0.05. 174 
RESULTS 175 
Characteristics of the study population at baseline 176 
The BSD score ranged from 1 to 25 in our population, and the mean was 13 points. In the model adjusted 177 
for age and energy intake the consumption of positive BSD score components (fruits, berries, vegetables, 178 
fiber from cereals, fish, milk with fact content <2%, and PUFA to SFA ratio) were substantially higher, 179 
and intakes of negative BSD score components (sausage and total fat energy %) were lower in higher 180 
score quartiles. At the baseline, women with higher adherence to BSD were more likely to be nonsmokers 181 
and engage more in physical activity (Table 2). The mean for MED score was 4.7 and ranged from 0 to 182 
8. Energy intake was significantly higher in the higher quartile of MED score (Table 3). Consumptions 183 
of fruits, vegetables, potato, legumes and nuts, milk and dairy products were significantly higher in higher 184 
MED score quartiles. Sarcopenic women (n = 127) had significantly lower mean weight (-13.2%), BMI 185 
(-12.7%), FM (-16.0%) and LM (-12.0%) as compared to non-sarcopenic group (n =398) (supplementary 186 
table 1). Sarcopenic women had also higher protein intake (g/kg BW), higher PUFA to SAFA ratio and 187 
higher MUFA+ PUFA to SAFA ratio. At the 3 year of follow-up 386 women were non-sarcopenic and 188 
139 were sarcopenic, whereas in the control group 216 women were classified as non-sarcopenic and 66 189 
as sarcopenic. There were no significant differences in baseline characteristics between intervention and 190 
control groups (data not shown). 191 
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Association of BSD score and sarcopenia indices at the baseline and over 3-year follow-up 192 
At the baseline, in model 2 women in the higher quartiles of BSD score had significantly greater LM (P 193 
trend = 0.044), faster walking speed 10m (P trend = 0.006), and longer one leg stance performance (P trend = 194 
0.050). Those women had higher SPPB score (P trend = 0.034) and better LBMQ (P trend = 0.017) (Table 195 
4). BSD score was non-significantly associated also with lower mobility disability (P trend = 0.051). In 196 
prospective analysis, women in the highest quartile of BSD score lost less RSMI (P trend = 0.022) and 197 
total body LM (P trend = 0.015) as compared to those in lower quartiles (Figure 1). Further, in the analyses 198 
using BSD score as continuous variable, a positive cross-sectional association with total body LM, 199 
walking speed, LBMQ and SPPB was observed, whereas BSD score as a continuous variable was 200 
positively associated with proportional changes of RSMI and total body LM over the 3-year follow-up 201 
(supplementary table 2). The interaction of BSD with interventional vitamin D and calcium 202 
supplementation was not significant (P ≥ 0·180). In the stratified prospective analysis in the control 203 
group, women in lowest quartile of BSD score lost more RSMI (P trend = 0.018), and total body LM (P 204 
trend = 0.004). Women in the highest BSD score quartile, showed the highest SPPB improvement (P trend 205 
= 0.041), had a 55% higher squat test completion (OR: 0.45; 95% CI: 0.11-0.98) and 67% lower risk of 206 
sarcopenia (OR: 0.33; 95% CI: 0.13, 0.79) as compared to the lowest quartile, over 3 year of follow-up 207 
(supplementary table 3). Similar results were observed using the BSD score as continuous variable (data 208 
not shown). 209 
Association of MED score and sarcopenia indices at the baseline and over 3-year follow-up 210 
Women in the higher quartiles of MED score had significantly faster walking speed 10m (P trend = 0.041), 211 
greater LBMQ (P trend = 0.017) at the baseline (Table 4). In prospective analysis, women in the lowest 212 
quartile of MED score lost more RSMI (P trend = 0.001) and total body LM (P trend = 0.008) as compared 213 
to those in higher quartiles (Figure 2). When using MED score as a continuous variable, a significant 214 
positive association was observed with walking speed and knee extension at the baseline and with 215 
proportional changes of RSMI and total body LM over the 3-year follow-up (supplementary table 2). 216 
The interaction of MED score with vitamin D and calcium supplementation was not significant (P ≥ 217 
0.730). In the stratified analysis using only the control group, women in the lowest quartile of MED score 218 
had higher loss of RSMI (P trend = 0.007) and total body LM (P trend = 0.001) over the 3-year follow-up 219 
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(supplementary table 3). We observed the similar results using the MED score as continuous variable 220 
(data not shown). 221 
Association of BSD and MED score components with sarcopenia indices 222 
We assessed further the associations of the BSD and MED score components with total body LM and PF 223 
at the baseline and over the 3-year follow-up with same adjustment as in model 2 (age, energy intake, 224 
smoking, total physical activity, hormone therapy, osteoporosis, rheumatoid arthritis, income per month, 225 
and fat mass percentage). Results showed no significant associations except that higher total fruit and 226 
vegetable (excluding potato) consumptions were positively associated (β ≥ 0.08 and P≤ 0.049) with 227 
walking speed 10 m, while higher alcohol consumption was negatively associated with walking speed 228 
10 m at the baseline (β= -0.30 and P= 0.034) (data not shown).  229 
DISCUSSION 230 
This cross-sectional and prospective study addressed the associations of BSD and MED with sarcopenia 231 
indices in elderly women. Findings of our study indicated that women with the lower adherence to BSD 232 
and MED lost more RSMI and total body LM as compared to those with higher adherence over the 3-233 
year follow-up. The cross-sectional results showed that better adherence to BSD was associated with 234 
greater total body LM, faster walking speed 10 m, longer one leg stance performance, higher SPPB score, 235 
and greater LBMQ at the baseline. Those with higher adherence to BSD tended to have lower risk of 236 
mobility disability. Further, women with higher adherence to MED had faster walking speed 10 m and 237 
greater LBMQ at the baseline. One explanation to the attenuation observed in the prospective analysis 238 
could be the small changes in PF measures over of the 3-year follow-up. The associations of the 239 
components of BSD and MED with muscle and PF measures were not significant; except for the 240 
association of fruits and vegetables with walking speed 10 m. Therefore, consistent with previous studies, 241 
the overall quality of diet might have more importance than only one food item [11, 29] , and it might 242 
not be sufficient to measure only one food item. 243 
Vitamin D supplementation can potentially affect muscle mass and PF in the elderly [30-32]. Given that 244 
about half of the subject in this study received calcium and vitamin D supplementation over the 3-year 245 
follow-up, we performed stratified analysis to evaluate the association of BSD and MED with sarcopenia 246 
indices only in the control group. Among women in the control group, lower adherence to BSD was 247 
associated with greater loss of RSMI and total body LM. Those women with higher adherence to BSD 248 
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had better SPPB, better results in squat test and lower risk of sarcopenia over the 3-year follow-up. Lower 249 
adherence to MED was associated also with greater loss of RSMI and total body LM. Further analysis in 250 
the present data showed no significant effect of vitamin D and calcium supplementation on muscle mass 251 
and PF measures (M.I, A.E and J.S, unpublished results), which was also explained elsewhere [18, 33]. 252 
Therefore, the possibility of vitamin D and calcium supplementation modification on the muscle mass 253 
and PF measures is not likely in this study. However, previous findings regarding the effect of vitamin 254 
D supplementation on sarcopenia are inconclusive [34, 35]. A recent meta-analysis suggested that 255 
vitamin D has no significant effect on muscle mass [34]. However, in a cross-sectional study that included 256 
2258 men and 3005 women aged ≥50 years, sarcopenia (defined as appendicular skeletal muscle 257 
mass/body weight <2 standard deviations below gender-specific means for young adults) was inversely 258 
associated with serum vitamin D levels in women, but not in men [36]. In another cohort study vitamin 259 
D status was associated with functional limitations cross-sectionally and longitudinally in individuals 260 
aged 55 to 65 years and those 65 years and older [37]. 261 
Our results are consistent with the existing, although limited, literature that supports an association 262 
between diet quality and PF in the elderly. In the recent prospective study among ageing women and 263 
men, a higher adherence to a healthy Nordic diet (similar to BSD) was associated with better physical 264 
performance 10 years later, including the 6-min walk, arm curl and chair stand tests, reflecting better 265 
aerobic endurance and upper- and lower-body strength [16]. Results of the InCHIANTI study [15], 266 
indicated that higher adherence to MED was associated with better lower body performance. Participants 267 
with higher adherence experienced less decline in SPPB score, at the 3, 6 and 9 year follow-up, compared 268 
to those with lower adherence. Higher adherence to MED at baseline was also associated with a lower 269 
risk of low physical activity and low walking speed but not with feelings of exhaustion and poor muscle 270 
strength. In the study by Shahar et al.[13]  among 2225 well-functioning men and women aged ≥ 70 271 
years, over 8 years of follow-up, both usual and rapid 20 m walking speed declined in the three MED 272 
adherence groups; however, the group with the highest adherence to the MED performed better at all 273 
time points. 274 
Multiple mechanisms can explain the effects of BSD and MED on LM and PF in the elderly. Oxidative 275 
stress is a major mechanism implicated in the pathogenesis of sarcopenia, and aging muscle shows 276 
increased oxidative damage to DNA, protein, and lipids [38, 39]. High intake of fruits and vegetables in 277 
MED and BSD could provide antioxidants such as vitamin C, vitamin E and carotenoids. Carotenoids 278 
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and antioxidants quench free radicals, reduce damage from reactive oxygen species, and appear to 279 
modulate redox-sensitive transcription factors (such as NF-κB, IL-6 and other proinflammatory 280 
cytokines) [6, 40, 41]. Recent epidemiological studies in community-dwelling older adults show that low 281 
serum/plasma carotenoids and vitamin E are independently associated with low skeletal muscle strength 282 
and the development of walking disability [42-44]. There were significantly higher intakes of 283 
carotenoids, vitamin E and vitamin C in the highest quartiles of BSD and MED score (Table 2 and 3). In 284 
contrast, intakes of fat and processed meat are related to increased oxidation and inflammation [45] . 285 
Those in the lowest BSD score quartile had significantly higher fat and sausage intakes. However, fat, 286 
total meat and sausage intakes were not significantly different by MED score quartiles. This can be 287 
explained by that total fat intake was not included in MED score construction. In addition, dietary fat 288 
quality might have more importance than the total fat intake. Both MED and BSD are characterized by 289 
high PUFA and MUFA intake to SFA ratio [8, 11]. Intake of n-3 PUFA (EPA, DHA and ALA) which 290 
are known for their anti-inflammatory properties were related to leg strength and chair-rise capacity [46], 291 
and similarly consumption of fatty fish (as enriched source of PUFAs) to grip strength [47]. In addition, 292 
n-3 PUFAs have potential to stimulate the muscle protein synthesis and subsequently muscle mass 293 
production [48]. In the InCHIANTI study, serum levels of n-3 PUFA were related to physical 294 
performance [49]. This suggests that the anti-inflammatory actions of n-3 PUFA may play a role in the 295 
prevention of sarcopenia. 296 
Compared to younger adults, older adults have lower rates of protein synthesis and propensity to eat less, 297 
leading to lower protein intake [50]. We have previously shown that dietary protein intake was positively 298 
associated with LM, appendicular LM and trunk LM [33]. Moreover, in this data those women with 299 
protein intake higher than 0.8 g/kg body weight/day had less decline in handgrip strength/ body weight, 300 
one leg stance and walking 6 m over 3 years (significances were attenuated after controlling for FM) 301 
[18]. The overall dietary protein intake was higher in the highest BSD score quartile (1.10 g/kg BW) than 302 
in the lowest (0.87 g/kg BW); as well as in the highest MED score quartile (1.05 g/kg BW) than in the 303 
lowest quartile (0.93 g/kg BW) (Tables 2 and 3). Difference in protein intake can partially explain the 304 
mechanism by which women with lower adherence to BSD and MED had greater decline in total body 305 
LM and RSMI. 306 
In our study, associations of MED and BSD with muscle strength measures (handgrip strength and chair 307 
rises) were not significant. Thus, it might be that higher adherence to MED and BSD can be more related 308 
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to preserving lower extremity muscle strength (walking speed and one leg stance) rather than upper 309 
extremity muscle strength [16]. Women with higher adherence to BSD tended to have lower mobility 310 
disability as compared to those with lower adherence. It has been shown that intake of dietary long-chain 311 
n-3 PUFAs was associated with decreased risk of developing rheumatoid arthritis as chronic 312 
inflammatory disease of joints that can affect the walking speed in the elderly [51], which may partially 313 
explain the MED and mobility disability association [52]. 314 
There were general similarities between the components of BSD and MED in our study as they are rich 315 
in fruits, vegetables, and fiber. Findings of our study in a non-Mediterranean country (Finland) suggested 316 
that either BSD or MED (adapted to Nordic foods consumption) could be beneficial to prevent sarcopenia 317 
in Finnish elderly women. However, we observed stronger associations in the analysis using BSD as 318 
compared to MED. Thus, due to the diversity in construction of MED and difficulty of its application in 319 
Nordic countries alongside with food culture differences; BSD could facilitate recommending a healthy 320 
diet for elderly Nordic populations. 321 
Current study has important strengths including the use of dual-energy X-ray absorptiometry to obtain 322 
total and regional body composition measures, use of extensive indices of sarcopenia, including LM, 323 
RSMI and PF measures as well as reporting both cross-sectional and prospective results. The PF 324 
measures and their changes have been applied and explained in this data set previously [18]. We have 325 
used categories based on distribution for BSD and MED rather than cut-off points based on 326 
recommendation.   327 
There are some potential limitations that need to be considered while interpreting the results. First, the 328 
dietary intake assessment was obtained only at the baseline, which may be insufficient to capture long-329 
term dietary exposures. The imprecision of the dietary data may have reduced the ability to detect more 330 
robust associations between dietary scores and changes in PF. Second, lower adherence to BSD and MED 331 
might be linked to the inferior health of a participant and since we do not have information on the 332 
participants’ earlier health status and eating patterns, reverse causality is possible. For instance, those 333 
with higher BSD score were more physically active than those with lower BSD score. Third, even though 334 
we were able to adjust for a wide range of potential confounders, the possibility of other residual 335 
confounding cannot be excluded. The study included relatively healthy elderly women from a rather 336 
homogenous Finnish population, so caution should be taken in generalization of the results to the entire 337 
elderly population. Fourth, we used income per month as a proxy of socioeconomic status. However, 338 
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association of income and dietary scores were not significant. Finally, the observational nature of our 339 
study did not allow us to evaluate a causal association between dietary scores and changes in RSMI and 340 
LM. 341 
This study have encouraging public health message that adherence to healthy BSD and MED could 342 
prevent sarcopenia with preserving LM. It is well documented that the loss of LM is associated with 343 
critical illnesses and sarcopenia. Further, although only at cross-sectional setting, a healthy diet was 344 
associated with better PF measures in elderly women. Previous studies have shown positive relation of 345 
BSD and MED with better physical performance, lower abdominal obesity, cognitive function and lower 346 
risk of metabolic syndrome [8, 10, 11, 16]. Thus, healthy MED or BSD seem to enhance overall health, 347 
physical performance as well as preventing sarcopenia in the elderly.  348 
In conclusion, a higher adherence to BSD and MED might be beneficial in prevention of sarcopenia, 349 
since women with lower adherence to BSD and MED lost more RSMI and total body LM compared to 350 
others. However, associations of BSD and MED with PF measures were more pronounced in cross-351 
sectional setting. This highlights the importance of a whole diet, not only single foods or nutrients. 352 
Further longitudinal studies are warranted to substantiate these recommendations. 353 
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